Survival in cats with primary and secondary cardiomyopathies - PubMed (original) (raw)
Survival in cats with primary and secondary cardiomyopathies
Ilaria Spalla et al. J Feline Med Surg. 2016 Jun.
Abstract
Objectives: Feline cardiomyopathies (CMs) represent a heterogeneous group of myocardial diseases. The most common CM is hypertrophic cardiomyopathy (HCM), followed by restrictive cardiomyopathy (RCM). Studies comparing survival and outcome for different types of CM are scant. Furthermore, little is known about the cardiovascular consequences of systemic diseases on survival. The aim of this retrospective study was to compare survival and prognostic factors in cats affected by HCM, RCM or secondary CM referred to our institution over a 10 year period.
Methods: The study included 94 cats with complete case records and echocardiographic examination. Fifty cats presented HCM, 14 RCM and 30 secondary CM.
Results: A statistically significant difference in survival time was identified for cats with HCM (median survival time of 865 days), RCM (273 days) and secondary CM (<50% cardiac death rate). In the overall population and in the primary CM group (HCM + RCM), risk factors in the multivariate analysis, regardless of the CM considered, were the presence of clinical signs, an increased left atrial to aortic root (LA/Ao) ratio and a hypercoagulable state.
Conclusions and relevance: Primary CMs in cats share some common features (ie, LA dimension and hypercoagulable state) linked to feline cardiovascular physiology, which influence survival greatly in end-stage CM. The presence of clinical signs has to be regarded as a marker of disease severity, regardless of the underlying CM. Secondary CMs are more benign conditions, but if the primary disease is not properly managed, the prognosis might also be poor in this group of patients.
© ISFM and AAFP 2015.
Conflict of interest statement
The authors do not have any potential conflicts of interest to declare.
Figures
Figure 1
Kaplan–Meier survival curves in the overall population regarding type of cardiomyopathy, presence of clinical signs, left atrial to aortic root (LA/Ao) ratio and echocardiographic signs of a hypercoagulable state; a different survival time was identified in every category, as depicted. In the hypertrophic cardiomyopathy (HCM) and restrictive cardiomyopathy (RCM) group, a different survival time was observed depending on the echocardiographic pattern of hypertrophy. Log-rank P value is shown in each graph. CM = cardiomyopathy; IVS = interventricular septum; LVFW = left ventricular free wall
Similar articles
- The Feline Cardiomyopathies: 3. Cardiomyopathies other than HCM.
Kittleson MD, Côté E. Kittleson MD, et al. J Feline Med Surg. 2021 Nov;23(11):1053-1067. doi: 10.1177/1098612X211030218. J Feline Med Surg. 2021. PMID: 34693805 Free PMC article. - Survival and prognostic factors in cats with restrictive cardiomyopathy: a review of 90 cases.
Locatelli C, Pradelli D, Campo G, Spalla I, Savarese A, Brambilla PG, Bussadori C. Locatelli C, et al. J Feline Med Surg. 2018 Dec;20(12):1138-1143. doi: 10.1177/1098612X18755955. Epub 2018 Feb 16. J Feline Med Surg. 2018. PMID: 29451444 Free PMC article. - The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy.
Kittleson MD, Côté E. Kittleson MD, et al. J Feline Med Surg. 2021 Nov;23(11):1028-1051. doi: 10.1177/1098612X211020162. J Feline Med Surg. 2021. PMID: 34693811 Free PMC article. - Animal models of primary myocardial diseases.
Liu SK, Tilley LP. Liu SK, et al. Yale J Biol Med. 1980 May-Jun;53(3):191-211. Yale J Biol Med. 1980. PMID: 6447412 Free PMC article. Review. - Management of asymptomatic (occult) feline cardiomyopathy: Challenges and realities.
Fox PR, Schober KA. Fox PR, et al. J Vet Cardiol. 2015 Dec;17 Suppl 1:S150-8. doi: 10.1016/j.jvc.2015.03.004. J Vet Cardiol. 2015. PMID: 26776574 Review.
Cited by
- Computed tomographic evaluation of heart size in clinically healthy cats.
Wanglerm A, Samachikthummakun C, Kitnitchee Z, Sirinitikorn T, Junnong S, Sutthigran S, Choisunirachon N, Thanaboonnipat C. Wanglerm A, et al. Open Vet J. 2023 Mar;13(3):337-347. doi: 10.5455/OVJ.2023.v13.i3.10. Epub 2023 Mar 15. Open Vet J. 2023. PMID: 37026074 Free PMC article. - A Questionnaire Survey on Long-Term Outcomes in Cats Breed-Screened for Feline Cardiomyopathy.
Follby A, Pettersson A, Ljungvall I, Ohlsson Å, Häggström J. Follby A, et al. Animals (Basel). 2022 Oct 15;12(20):2782. doi: 10.3390/ani12202782. Animals (Basel). 2022. PMID: 36290168 Free PMC article. - Ambulatory electrocardiography, heart rate variability, and pharmacologic stress testing in cats with subclinical hypertrophic cardiomyopathy.
Walker AL, Ueda Y, Crofton AE, Harris SP, Stern JA. Walker AL, et al. Sci Rep. 2022 Feb 4;12(1):1963. doi: 10.1038/s41598-022-05999-x. Sci Rep. 2022. PMID: 35121794 Free PMC article. - Retrospective evaluation of the safety and tolerability of pimobendan in cats with obstructive vs nonobstructive cardiomyopathy.
Ward JL, Kussin EZ, Tropf MA, Tou SP, DeFrancesco TC, Keene BW. Ward JL, et al. J Vet Intern Med. 2020 Nov;34(6):2211-2222. doi: 10.1111/jvim.15920. Epub 2020 Oct 7. J Vet Intern Med. 2020. PMID: 33026124 Free PMC article. - Occurrences of heart disease in apparently healthy cats in Klang Valley, Malaysia.
Khor KH, Chin MX. Khor KH, et al. J Adv Vet Anim Res. 2020 Aug 22;7(3):501-508. doi: 10.5455/javar.2020.g446. eCollection 2020 Sep. J Adv Vet Anim Res. 2020. PMID: 33005676 Free PMC article.
References
- Elliot P, Andersson B, Arbustini E, et al.. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2006; 29: 270–276. - PubMed
- Coté E, Macdonald K, Meurs K, et al.. Feline cardiology. 1st ed. Somerset, NJ: Wiley-Blackwell, 2011.
- Boon J. Veterinary echocardiography. 2nd ed. Chichester: Wiley-Blackwell, 2011, pp 37–255.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous